Search
Search Results
##search.searchResults.foundPlural##
-
GROWTH AND ENDOCRINE FUNCTION IN TUNISIAN THALASSEMIA MAJOR PATIENTS
2804PDF: 1026HTML: 422TABLE: 195FIGURES: 259 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8045PDF: 4244HTML: 7510 -
Mantle cell lymphoma relapsing at the lymphedematous arm.
1717PDF: 702HTML: 3801 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1127PDF: 550HTML: 1698Figures: 173Fifures Sanz: 180tables Sanz: 184Untitled: 182 -
STUDY OF SERUM HAPTOGLOBIN LEVEL AND ITS RELATION TO ERYTHROPOIETIC ACTIVITY IN BETA THALASSEMIA CHILDREN .
2222PDF: 1176HTML: 2595Study of serum haptoglobin level in thalassemia: 350Figures: 183 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
1995PDF: 730HTML: 688Table1: patient's characteristics: 160Table 2: profile of each patient: 183 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4553PDF: 1941HTML: 17805 -
Clinical and laboratory features of Hemoglobin La Desirade variant in association with sickle cell and alpha thalassemia genes Clinical & laboratory features of Hb La Desirade trait and compound heterozygous for Hb La Desirade and HbS Hemoglobin.
1642PDF: 477HTML: 254 -
Anemia in the elderly: not always what it seems.
3332PDF: 1077HTML: 1783Figure 1: 184Figure 1 revised: 185 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3314PDF: 1257HTML: 8123 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4386PDF: 1772HTML: 1111 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4405PDF: 924HTML: 1329Table1: 185 -
Measurement of erythrocyte lifespan using a CO breath test in patients with thalassemia and the impact of treatment erythrocyte lifespan in patients with thalassemia
774PDF: 554HTML: 173 -
A strange case of Malaria in a Nigerian native boy.
2456PDF: 867HTML: 1308 -
Acquired Hemophilia A successfully treated with rituximab
1966PDF: 1156HTML: 1459Figure 1: 183 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
1994PDF: 769HTML: 702 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3344PDF: 1367HTML: 2674 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1782PDF: 1180HTML: 253 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1784PDF: 582HTML: 288 -
IMPORTANCE OF HYPERBILURUBINEMIA IN DIFFERENTIATION OF PRIMARY AND SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN PEDIATRIC CASES
1795PDF: 946HTML: 1115Untitled: 159Untitled: 177Untitled: 162Untitled: 167







